{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T11:51:45Z","timestamp":1792237905684,"version":"4.4.0"},"reference-count":60,"publisher":"American Association for Cancer Research (AACR)","issue":"11","license":[{"start":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T00:00:00Z","timestamp":1699315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"HHS | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["ZIA BC 010887"],"award-info":[{"award-number":["ZIA BC 010887"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016400","name":"National Research Fund, Kenya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016400","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"HHS | NIH | National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Women of African descent have the highest breast cancer mortality in the United States and are more likely than women from other population groups to develop an aggressive disease. It remains uncertain to what extent breast cancer in Africa is reminiscent of breast cancer in African American or European American patients. Here, we performed whole-exome sequencing of genomic DNA from 191 breast tumor and non-cancerous adjacent tissue pairs obtained from 97 African American, 69 European American, 2 Asian American, and 23 Kenyan patients. Our analysis of the sequencing data revealed an elevated tumor mutational burden in both Kenyan and African American patients, when compared with European American patients. TP53 mutations were most prevalent, particularly in African American patients, followed by PIK3CA mutations, which showed similar frequencies in European American, African American, and the Kenyan patients. Mutations targeting TBX3 were confined to European Americans and those targeting the FBXW7 tumor suppressor to African American patients whereas mutations in the ARID1A gene that are known to confer resistance to endocrine therapy were distinctively enriched among Kenyan patients. A Kyoto Encyclopedia of Genes and Genomes pathway analysis could link FBXW7 mutations to an increased mitochondrial oxidative phosphorylation capacity in tumors carrying these mutations. Finally, Catalogue of Somatic Mutations in Cancer (COSMIC) mutational signatures in tumors correlated with the occurrence of driver mutations, immune cell profiles, and neighborhood deprivation with associations ranging from being mostly modest to occasionally robust. To conclude, we found mutational profiles that were different between these patient groups. The differences concentrated among genes with low mutation frequencies in breast cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>The study describes differences in tumor mutational profiles between African American, European American, and Kenyan breast cancer patients. It also investigates how these profiles may relate to the tumor immune environment and the neighborhood environment in which the patients had residence. Finally, it describes an overrepresentation of ARID1A gene mutations in breast tumors of the Kenyan patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-23-0165","type":"journal-article","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T09:19:32Z","timestamp":1698657572000},"page":"2244-2255","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Population-specific Mutation Patterns in Breast Tumors from African American, European American, and Kenyan Patients"],"prefix":"10.1158","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7089-4391","authenticated-orcid":true,"given":"Wei","family":"Tang","sequence":"first","affiliation":[{"name":"1Laboratory of Human Carcinogenesis, Center for Cancer Research, NCI, NIH, Bethesda, Maryland."},{"name":"2Data Science & Artificial Intelligence, R&D, AstraZeneca, Gaithersburg, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5150-671X","authenticated-orcid":true,"given":"Flora","family":"Zhang","sequence":"additional","affiliation":[{"name":"1Laboratory of Human Carcinogenesis, Center for Cancer Research, NCI, NIH, Bethesda, Maryland."},{"name":"3Colgate University, Hamilton, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7948-4818","authenticated-orcid":true,"given":"Jung S.","family":"Byun","sequence":"additional","affiliation":[{"name":"4Division of Intramural Research, National Institute of Minority Health and Health Disparities, NIH, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1334-0098","authenticated-orcid":true,"given":"Tiffany H.","family":"Dorsey","sequence":"additional","affiliation":[{"name":"1Laboratory of Human Carcinogenesis, Center for Cancer Research, NCI, NIH, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3076-9627","authenticated-orcid":true,"given":"Harris G.","family":"Yfantis","sequence":"additional","affiliation":[{"name":"5Department of Pathology, University of Maryland Medical Center and Veterans Affairs, Maryland Care System, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6057-1276","authenticated-orcid":true,"given":"Anuoluwapo","family":"Ajao","sequence":"additional","affiliation":[{"name":"1Laboratory of Human Carcinogenesis, Center for Cancer Research, NCI, NIH, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7791-1502","authenticated-orcid":true,"given":"Huaitian","family":"Liu","sequence":"additional","affiliation":[{"name":"1Laboratory of Human Carcinogenesis, Center for Cancer Research, NCI, NIH, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9132-4400","authenticated-orcid":true,"given":"Margaret S.","family":"Pichardo","sequence":"additional","affiliation":[{"name":"1Laboratory of Human Carcinogenesis, Center for Cancer Research, NCI, NIH, Bethesda, Maryland."},{"name":"6Department of Surgery, Hospital of the University of Pennsylvania, Penn Medicine, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2520-4021","authenticated-orcid":true,"given":"Catherine M.","family":"Pichardo","sequence":"additional","affiliation":[{"name":"1Laboratory of Human Carcinogenesis, Center for Cancer Research, NCI, NIH, Bethesda, Maryland."},{"name":"7Division of Cancer Control and Population Sciences, NCI, NIH, Rockville, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1049-3131","authenticated-orcid":true,"given":"Alexandra R.","family":"Harris","sequence":"additional","affiliation":[{"name":"1Laboratory of Human Carcinogenesis, Center for Cancer Research, NCI, NIH, Bethesda, Maryland."},{"name":"8Integrative Tumor Epidemiology Branch, Division of Cancer Epidemiology and Genetics, NCI, Rockville, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4451-8664","authenticated-orcid":true,"given":"Xiaohong R.","family":"Yang","sequence":"additional","affiliation":[{"name":"8Integrative Tumor Epidemiology Branch, Division of Cancer Epidemiology and Genetics, NCI, Rockville, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5100-623X","authenticated-orcid":true,"given":"Jonine D.","family":"Figueroa","sequence":"additional","affiliation":[{"name":"8Integrative Tumor Epidemiology Branch, Division of Cancer Epidemiology and Genetics, NCI, Rockville, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3472-511X","authenticated-orcid":true,"given":"Shahin","family":"Sayed","sequence":"additional","affiliation":[{"name":"9Aga Khan University Hospital, Nairobi, Kenya."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3324-4426","authenticated-orcid":true,"given":"Francis W.","family":"Makokha","sequence":"additional","affiliation":[{"name":"10Mount Kenya University, Thika, Kenya."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7651-9309","authenticated-orcid":true,"given":"Stefan","family":"Ambs","sequence":"additional","affiliation":[{"name":"1Laboratory of Human Carcinogenesis, Center for Cancer Research, NCI, NIH, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2023,11,7]]},"reference":[{"key":"2023110714071535400_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"2023110714071535400_bib2","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1158\/1055-9965.EPI-16-0858","article-title":"Global cancer in women: burden and trends","volume":"26","author":"Torre","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2023110714071535400_bib3","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3322\/caac.21718","article-title":"Cancer statistics for African American\/Black People 2022","volume":"72","author":"Giaquinto","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"2023110714071535400_bib4","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","article-title":"Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study","volume":"295","author":"Carey","year":"2006","journal-title":"JAMA"},{"key":"2023110714071535400_bib5","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1001\/jamaoncol.2017.0595","article-title":"Comparison of breast cancer molecular features and survival by African and European ancestry in the cancer genome atlas","volume":"3","author":"Huo","year":"2017","journal-title":"JAMA Oncol"},{"key":"2023110714071535400_bib6","doi-asserted-by":"crossref","first-page":"pkac016","DOI":"10.1093\/jncics\/pkac016","article-title":"Breast Cancer incidence, hormone receptor status, historical redlining, and current neighborhood characteristics in massachusetts, 2005\u20132015","volume":"6","author":"Wright","year":"2022","journal-title":"JNCI Cancer Spectr"},{"key":"2023110714071535400_bib7","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1158\/1055-9965.EPI-22-0738","article-title":"Area-level socioeconomic disadvantage and cancer survival in metropolitan detroit","volume":"32","author":"Snider","year":"2023","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2023110714071535400_bib8","doi-asserted-by":"crossref","first-page":"11006","DOI":"10.1038\/s41598-022-15260-0","article-title":"Neighborhood disadvantage and biological aging biomarkers among breast cancer patients","volume":"12","author":"Shen","year":"2022","journal-title":"Sci Rep"},{"key":"2023110714071535400_bib9","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2559.2008.02966.x","article-title":"Pathological, clinical and prognostic characteristics of breast cancer in Central Sudan versus Northern Italy: implications for breast cancer in Africa","volume":"52","author":"Awadelkarim","year":"2008","journal-title":"Histopathology"},{"key":"2023110714071535400_bib10","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1200\/JCO.2008.19.6873","article-title":"Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer","volume":"27","author":"Huo","year":"2009","journal-title":"J Clin Oncol"},{"key":"2023110714071535400_bib11","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1038\/s41467-018-06616-0","article-title":"Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features","volume":"9","author":"Pitt","year":"2018","journal-title":"Nat Commun"},{"key":"2023110714071535400_bib12","doi-asserted-by":"crossref","first-page":"e055735","DOI":"10.1136\/bmjopen-2021-055735","article-title":"Triple-negative breast cancer prevalence in Africa: a systematic review and meta-analysis","volume":"12","author":"Hercules","year":"2022","journal-title":"BMJ Open"},{"key":"2023110714071535400_bib13","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10549-017-4511-2","article-title":"Ethnicity and breast cancer characteristics in Kenya","volume":"167","author":"Sayed","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"2023110714071535400_bib14","first-page":"1","article-title":"Metastatic breast cancer in kenya: presentation, pathologic characteristics, and patterns-findings from a tertiary cancer center","volume":"5","author":"Ekpe","year":"2019","journal-title":"J Glob Oncol"},{"key":"2023110714071535400_bib15","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/ng.985","article-title":"A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer","volume":"43","author":"Haiman","year":"2011","journal-title":"Nat Genet"},{"key":"2023110714071535400_bib16","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/SLA.0000000000003459","article-title":"Hereditary susceptibility for triple negative breast cancer associated with Western Sub-Saharan African ancestry: results from an international surgical breast cancer collaborative","volume":"270","author":"Newman","year":"2019","journal-title":"Ann Surg"},{"key":"2023110714071535400_bib17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10585-021-10087-x","article-title":"Breast cancer disparities in outcomes; unmasking biological determinants associated with racial and genetic diversity","volume":"39","author":"Martini","year":"2022","journal-title":"Clin Exp Metastasis"},{"key":"2023110714071535400_bib18","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1158\/2159-8290.CD-22-0138","article-title":"African ancestry-associated gene expression profiles in triple-negative breast cancer underlie altered tumor biology and clinical outcome in women of African descent","volume":"12","author":"Martini","year":"2022","journal-title":"Cancer Discov"},{"key":"2023110714071535400_bib19","doi-asserted-by":"crossref","first-page":"e4531","DOI":"10.1371\/journal.pone.0004531","article-title":"Differences in the tumor microenvironment between African-American and European-American breast cancer patients","volume":"4","author":"Martin","year":"2009","journal-title":"PLoS One"},{"key":"2023110714071535400_bib20","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10549-015-3474-4","article-title":"Race-associated biological differences among Luminal A breast tumors","volume":"152","author":"D'Arcy","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"2023110714071535400_bib21","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s10552-017-0955-2","article-title":"Kaiso is highly expressed in TNBC tissues of women of African ancestry compared to Caucasian women","volume":"28","author":"Bassey-Archibong","year":"2017","journal-title":"Cancer Causes Control"},{"key":"2023110714071535400_bib22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13058-019-1191-3","article-title":"A functional role for the cancer disparity-linked genes, CRYbetaB2 and CRYbetaB2P1, in the promotion of breast cancer","volume":"21","author":"Barrow","year":"2019","journal-title":"Breast Cancer Res"},{"key":"2023110714071535400_bib23","doi-asserted-by":"crossref","first-page":"5752","DOI":"10.1038\/s41388-021-01975-3","article-title":"CRYbetaB2 enhances tumorigenesis through upregulation of nucleolin in triple negative breast cancer","volume":"40","author":"Yan","year":"2021","journal-title":"Oncogene"},{"key":"2023110714071535400_bib24","doi-asserted-by":"crossref","first-page":"e157465","DOI":"10.1172\/jci.insight.157465","article-title":"Protein expression of the gp78 E3 ligase predicts poor breast cancer outcome based on race","volume":"7","author":"Singhal","year":"2022","journal-title":"JCI Insight"},{"key":"2023110714071535400_bib25","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ccell.2018.08.019","article-title":"Integrated analysis of genetic ancestry and genomic alterations across cancers","volume":"34","author":"Yuan","year":"2018","journal-title":"Cancer Cell"},{"key":"2023110714071535400_bib26","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s10552-022-01574-x","article-title":"Analysis of the genomic landscapes of Barbadian and Nigerian women with triple negative breast cancer","volume":"33","author":"Hercules","year":"2022","journal-title":"Cancer Causes Control"},{"key":"2023110714071535400_bib27","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/jnci\/djj245","article-title":"Association of breast cancer outcome with status of p53 and MDM2 SNP309","volume":"98","author":"Boersma","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"2023110714071535400_bib28","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1172\/JCI71180","article-title":"MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis","volume":"124","author":"Terunuma","year":"2014","journal-title":"J Clin Invest"},{"key":"2023110714071535400_bib29","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/nm.3909","article-title":"The prognostic landscape of genes and infiltrating immune cells across human cancers","volume":"21","author":"Gentles","year":"2015","journal-title":"Nat Med"},{"key":"2023110714071535400_bib30","unstructured":"Geolytics. Neighborhood change database [NCDB] tract data from 1970\u20132010; 2014. Available from: https:\/\/geolytics.com\/products\/normalized-data\/neighborhood-change-database."},{"key":"2023110714071535400_bib31","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s11524-006-9094-x","article-title":"The development of a standardized neighborhood deprivation index","volume":"83","author":"Messer","year":"2006","journal-title":"J Urban Health"},{"key":"2023110714071535400_bib32","doi-asserted-by":"crossref","first-page":"e2251745","DOI":"10.1001\/jamanetworkopen.2022.51745","article-title":"Association of neighborhood deprivation with prostate cancer and immune markers in African American and European American Men","volume":"6","author":"Pichardo","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2023110714071535400_bib33","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023110714071535400_bib34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"Hanzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"2023110714071535400_bib35","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s43018-019-0009-7","article-title":"Higher prevalence of homologous recombination deficiency in tumors from African Americans versus European Americans","volume":"1","author":"Sinha","year":"2020","journal-title":"Nat Cancer"},{"key":"2023110714071535400_bib36","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10983","article-title":"The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups","volume":"486","author":"Curtis","year":"2012","journal-title":"Nature"},{"key":"2023110714071535400_bib37","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12943-022-01548-2","article-title":"Clinical significance of FBXW7 loss of function in human cancers","volume":"21","author":"Fan","year":"2022","journal-title":"Mol Cancer"},{"key":"2023110714071535400_bib38","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ccell.2020.04.012","article-title":"Comprehensive analysis of genetic ancestry and its molecular correlates in cancer","volume":"37","author":"Carrot-Zhang","year":"2020","journal-title":"Cancer Cell"},{"key":"2023110714071535400_bib39","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1172\/JCI127579","article-title":"ERR1 and PGC1alpha associated mitochondrial alterations correlate with pan-cancer disparity in African Americans","volume":"129","author":"Piyarathna","year":"2019","journal-title":"J Clin Invest"},{"key":"2023110714071535400_bib40","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the catalogue of somatic mutations in cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2023110714071535400_bib41","doi-asserted-by":"crossref","first-page":"6946","DOI":"10.1038\/s41467-021-27079-w","article-title":"Whole-genome analysis of Nigerian patients with breast cancer reveals ethnic-driven somatic evolution and distinct genomic subtypes","volume":"12","author":"Ansari-Pour","year":"2021","journal-title":"Nat Commun"},{"key":"2023110714071535400_bib42","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13073-022-01016-y","article-title":"Somatic mutational profiles and germline polygenic risk scores in human cancer","volume":"14","author":"Liu","year":"2022","journal-title":"Genome Med"},{"key":"2023110714071535400_bib43","first-page":"100076","article-title":"Comparison of somatic mutation landscapes in Chinese versus European breast cancer patients","volume":"3","author":"Zhu","year":"2022","journal-title":"HGG Adv"},{"key":"2023110714071535400_bib44","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1158\/1055-9965.EPI-18-0955","article-title":"Atypical chemokine receptor 1 (DARC\/ACKR1) in breast tumors is associated with survival, circulating chemokines, tumor-infiltrating immune cells, and African ancestry","volume":"28","author":"Jenkins","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2023110714071535400_bib45","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12885-016-2204-6","article-title":"Aggressive breast cancer in western Kenya has early onset, high proliferation, and immune cell infiltration","volume":"16","author":"Sawe","year":"2016","journal-title":"BMC Cancer"},{"key":"2023110714071535400_bib46","doi-asserted-by":"crossref","first-page":"101086","DOI":"10.1016\/j.tranon.2021.101086","article-title":"Comparative analysis of triple-negative breast cancer transcriptomics of Kenyan, African American and Caucasian Women","volume":"14","author":"Saleh","year":"2021","journal-title":"Transl Oncol"},{"key":"2023110714071535400_bib47","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature11017","article-title":"The landscape of cancer genes and mutational processes in breast cancer","volume":"486","author":"Stephens","year":"2012","journal-title":"Nature"},{"key":"2023110714071535400_bib48","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3389\/fonc.2015.00244","article-title":"Putative breast cancer driver mutations in TBX3 cause impaired transcriptional repression","volume":"5","author":"Fischer","year":"2015","journal-title":"Front Oncol"},{"key":"2023110714071535400_bib49","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.1073\/pnas.1718338115","article-title":"Pan-cancer transcriptional signatures predictive of oncogenic mutations reveal that Fbw7 regulates cancer cell oxidative metabolism","volume":"115","author":"Davis","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023110714071535400_bib50","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41588-019-0554-0","article-title":"ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer","volume":"52","author":"Xu","year":"2020","journal-title":"Nat Genet"},{"key":"2023110714071535400_bib51","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1002\/cncr.25276","article-title":"African ancestry and higher prevalence of triple-negative breast cancer: findings from an international study","volume":"116","author":"Stark","year":"2010","journal-title":"Cancer"},{"key":"2023110714071535400_bib52","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0140-6736(20)32531-9","article-title":"Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial","volume":"396","author":"Cortes","year":"2020","journal-title":"Lancet"},{"key":"2023110714071535400_bib53","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41523-022-00486-y","article-title":"Immunotherapy in triple negative breast cancer: beyond checkpoint inhibitors","volume":"8","author":"Abdou","year":"2022","journal-title":"NPJ Breast Cancer"},{"key":"2023110714071535400_bib54","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.tranon.2019.10.010","article-title":"Homologous recombination repair deficiency and the immune response in breast cancer: a literature review","volume":"13","author":"Pellegrino","year":"2020","journal-title":"Transl Oncol"},{"key":"2023110714071535400_bib55","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/jamaoncol.2019.1029","article-title":"Open-label clinical trial of niraparib combined with pembrolizumab for treatment of advanced or metastatic triple-negative breast cancer","volume":"5","author":"Vinayak","year":"2019","journal-title":"JAMA Oncol"},{"key":"2023110714071535400_bib56","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10549-011-1646-4","article-title":"Elevated PCNA+ tumor-associated macrophages in breast cancer are associated with early recurrence and non-Caucasian ethnicity","volume":"130","author":"Mukhtar","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"2023110714071535400_bib57","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13058-020-01297-4","article-title":"Racial differences in CD8(+) T cell infiltration in breast tumors from Black and White women","volume":"22","author":"Abdou","year":"2020","journal-title":"Breast Cancer Res"},{"key":"2023110714071535400_bib58","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/sj.bjc.6605540","article-title":"p53 mutation, deprivation and poor prognosis in primary breast cancer","volume":"102","author":"Baker","year":"2010","journal-title":"Br J Cancer"},{"key":"2023110714071535400_bib59","doi-asserted-by":"crossref","first-page":"e57361","DOI":"10.1371\/journal.pone.0057361","article-title":"Household income is associated with the p53 mutation frequency in human breast tumors","volume":"8","author":"Starks","year":"2013","journal-title":"PLoS One"},{"key":"2023110714071535400_bib60","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1158\/1078-0432.CCR-15-2840","article-title":"The genomic landscape of male breast cancers","volume":"22","author":"Piscuoglio","year":"2016","journal-title":"Clin Cancer Res"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-23-0165\/3378335\/crc-23-0165.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/3\/11\/2244\/3380735\/crc-23-0165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/3\/11\/2244\/3380735\/crc-23-0165.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T09:09:24Z","timestamp":1699348164000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/3\/11\/2244\/730015\/Population-specific-Mutation-Patterns-in-Breast"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,7]]},"references-count":60,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11,7]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-23-0165","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.24517849","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24517867.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24517876.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24517873.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24517882.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24517855","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24517867","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24517879","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24517861","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24517873","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24517858.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24517870","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24517882","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24517849.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24517846.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24517858","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24517876","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24517846","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24517855.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24517864","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24517861.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24517879.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24517870.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24517864.v1","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.6918115","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.6918115.v1","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,7]]}}}